Loading stock data...

Metropolis Healthcare Limited

NSE: METROPOLIS BSE: METROPOLIS

NSE
1,652.20 -28.60 (-1.70%)

Prev Close

1680.8

Open Price

1695

Volume

78,720

Today Low / High

1645 / 1695

52 WK Low / High

1315 / 2318.3

Range

1,570 - 1,735

BSE
1,651.35 -27.75 (-1.65%)

Prev Close

1679.1

Open Price

1679.65

Volume

845

Today Low / High

1644.2 / 1679.65

52 WK Low / High

1383.7 / 2306.85

Range

1,569 - 1,734

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1652.2 (target range: 1,570 - 1,735), reflecting a change of -28.6 (-1.70157%). On the BSE, it is listed at 1651.35 (target range: 1,569 - 1,734), showing a change of -27.75 (-1.65267%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

06 Jun 1,695.00 -2.53%
05 Jun 1,708.00 -1.59%
04 Jun 1,715.20 -1.22%
03 Jun 1,656.00 3.41%
02 Jun 1,683.00 -1.07%
30 May 1,675.90 0.25%
29 May 1,682.00 -0.32%
28 May 1,669.80 0.08%
27 May 1,670.00 -0.01%
26 May 1,635.00 1.43%
23 May 1,625.80 0.03%
22 May 1,662.80 -2.13%
21 May 1,675.10 -0.78%
20 May 1,658.00 0.10%
19 May 1,645.00 -0.50%
16 May 1,640.00 0.54%
15 May 1,600.00 1.68%
14 May 1,694.00 -4.69%
13 May 1,711.20 -0.56%
12 May 1,690.00 1.32%
09 May 1,625.00 2.73%

Metropolis Healthcare Limited Graph

Metropolis Healthcare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Metropolis Healthcare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,652.20, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 1,651.35 1,667.86 1,501.08 - 1,834.65
1,684.38 1,347.50 - 2,021.25
1,700.89 1,190.62 - 2,211.16
Bearish Scenario 1,651.35 1,634.84 1,471.35 - 1,798.32
1,618.32 1,294.66 - 1,941.99
1,601.81 1,121.27 - 2,082.35

Overview of Metropolis Healthcare Limited

ISIN

INE112L01020

Industry

Medical - Diagnostics & Research

Vol.Avg

85,070

Market Cap

85,583,960,000

Last Dividend

0

Official Website

Visit Website

IPO Date

2019-04-15

DCF Diff

-3,247.32

DCF

4,877

Financial Ratios Every Investor Needs

Stock Dividend of METROPOLIS

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2023-11-17 November 17, 23 4 4 2023-11-17 2023-12-04
2023-02-23 February 23, 23 8 8 2023-02-23 2023-03-03
2022-02-21 February 21, 22 8 8 2022-02-22 2022-03-13
2021-02-17 February 17, 21 8 8 2021-02-19 2021-03-12
2020-02-13 February 13, 20 8 8 2020-02-15 2020-03-07 2020-02-03

Stock Rating Details for METROPOLIS

Metric Value Recommendation
Overall Rating C Sell
DCF Score 5 Strong Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2024-03-31 1,207.71 Cr 626.40 Cr 581.31 Cr 0.4813 0.00 Cr 360.43 Cr 203.40 Cr 127.82 Cr 24.95 296.99 Cr 0.1058
2023-03-31 1,148.21 Cr 259.83 Cr 888.38 Cr 0.7737 8.74 Cr 132.44 Cr 214.30 Cr 142.88 Cr 27.91 308.47 Cr 0.1244
2022-03-31 1,228.32 Cr 287.52 Cr 940.81 Cr 0.7659 8.91 Cr 84.06 Cr 279.57 Cr 214.18 Cr 41.87 381.30 Cr 0.1744
2021-03-31 997.79 Cr 260.21 Cr 737.58 Cr 0.7392 6.83 Cr 41.98 Cr 246.41 Cr 183.10 Cr 35.97 301.36 Cr 0.1835
2020-03-31 855.85 Cr 213.50 Cr 642.35 Cr 0.7505 8.09 Cr 37.37 Cr 177.30 Cr 127.33 Cr 25.36 220.58 Cr 0.1488

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2024-03-31 62.97 Cr 1,555.06 Cr 455.79 Cr 1,096.1555 Cr 197.06 Cr 134.45 Cr 38.69 Cr 336.37 Cr 0.00 Cr 0.00 Cr 6.87 Cr 245.8742 Cr
2023-03-31 68.83 Cr 1,501.61 Cr 510.90 Cr 988.2323 Cr 266.38 Cr 197.55 Cr 44.59 Cr 310.65 Cr 39.06 Cr 0.00 Cr -33.09 Cr 264.9709 Cr
2022-03-31 65.98 Cr 1,530.29 Cr 642.13 Cr 886.1978 Cr 378.56 Cr 312.58 Cr 51.11 Cr 248.73 Cr 55.73 Cr 0.00 Cr -89.63 Cr 301.5496 Cr
2021-03-31 386.59 Cr 1,004.42 Cr 296.35 Cr 706.6004 Cr 112.27 Cr -274.32 Cr 40.55 Cr 218.27 Cr 45.44 Cr 0.00 Cr -31.97 Cr 203.9555 Cr
2020-03-31 107.17 Cr 752.23 Cr 227.08 Cr 523.4961 Cr 66.70 Cr -40.47 Cr 24.40 Cr 180.86 Cr 12.44 Cr 4.68 Cr -96.50 Cr 169.4796 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2024-03-31 264.0699 Cr -89.4116 Cr -181.1985 Cr 200.3089 Cr -6.2149 Cr 62.6183 Cr -63.7610 Cr 127.8162 Cr -79.0523 Cr -20.4960 Cr 5.8977 Cr
2023-03-31 247.0898 Cr 46.7944 Cr -292.3288 Cr 194.4563 Cr 2.8528 Cr 68.8332 Cr -52.6335 Cr 187.5034 Cr -178.8668 Cr -40.9685 Cr 6.5150 Cr
2022-03-31 253.2746 Cr -737.5742 Cr 162.5210 Cr 222.6121 Cr -320.6130 Cr 65.9804 Cr -30.6625 Cr 293.3511 Cr 220.9320 Cr -40.9377 Cr -7.9373 Cr
2021-03-31 249.0285 Cr 61.7012 Cr -32.6901 Cr 220.7559 Cr 279.4192 Cr 386.5934 Cr -28.2726 Cr 244.3230 Cr -0.0351 Cr -40.8934 Cr -16.1476 Cr
2020-03-31 215.0008 Cr -104.8312 Cr -55.3232 Cr 178.7940 Cr 55.8032 Cr 107.1742 Cr -36.2068 Cr 168.7331 Cr -17.7442 Cr -48.3944 Cr 1.7016 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2024-12-31 322.77 Cr 66.95 Cr 255.82 Cr 0.7926 44.31 Cr 31.36 Cr 6.12 74.56 Cr 0.0972
2024-09-30 349.79 Cr 72.54 Cr 277.25 Cr 0.7926 63.06 Cr 46.52 Cr 9.08 93.01 Cr 0.1330
2024-06-30 313.36 Cr 163.04 Cr 150.31 Cr 0.4797 53.27 Cr 37.95 Cr 7.41 81.27 Cr 0.1211
2024-03-31 331.00 Cr 171.23 Cr 159.77 Cr 0.4827 53.56 Cr 36.41 Cr 7.11 82.52 Cr 0.1100
2023-12-31 291.12 Cr 59.34 Cr 231.78 Cr 0.7962 42.16 Cr 27.16 Cr 5.30 67.15 Cr 0.0933

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2024-09-30 44.39 Cr 146.38 Cr 190.77 Cr 0.00 Cr 37.14 Cr 390.29 Cr 335.76 Cr 1,631.23 Cr 443.83 Cr
2024-06-30 0.00 Cr 0.00 Cr 116.04 Cr 0.00 Cr 0.00 Cr 116.04 Cr 0.00 Cr 0.00 Cr -1,099.27 Cr
2024-03-31 71.22 Cr 53.07 Cr 124.29 Cr 126.28 Cr 38.69 Cr 315.83 Cr 336.03 Cr 1,555.06 Cr 455.79 Cr
2023-12-31 -107.46 Cr 214.91 Cr 107.46 Cr 0.00 Cr 0.00 Cr 107.46 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 50.93 Cr 64.44 Cr 115.37 Cr 122.90 Cr 43.58 Cr 302.71 Cr 316.64 Cr 1,509.14 Cr 459.77 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-06-30 37.95 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 36.41 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 27.16 Cr 49.98 Cr 0.00 Cr 0.00 Cr 49.98 Cr 100.91 Cr 50.93 Cr 0.00 Cr 49.98 Cr
2023-09-30 35.45 Cr 44.48 Cr 0.00 Cr 0.00 Cr 44.48 Cr 50.93 Cr 6.45 Cr 0.00 Cr 44.48 Cr
2023-06-30 28.80 Cr 41.64 Cr 0.00 Cr 0.00 Cr 41.64 Cr 110.95 Cr 69.31 Cr 0.00 Cr 41.64 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Diagnostics & Research

Company Name Symbol Price Market Cap Volume
Dr. Lal PathLabs Limited LALPATHLAB ₹2,846.20 ₹237,279,832,796.00 ₹76,488.00
Vijaya Diagnostic Centre Limited VIJAYA ₹975.00 ₹100,070,373,000.00 ₹277,592.00
Metropolis Healthcare Limited METROPOLIS ₹1,652.20 ₹85,583,960,000.00 ₹78,720.00
Thyrocare Technologies Limited THYROCARE ₹952.80 ₹50,492,206,800.00 ₹203,448.00

Key Executives

Founder & Chairman Emeritus
Dr. Sushil Kanubhai Shah

Gender: Not Specified

Year Born: 1946

Chief Information Officer
Mr. Pinakin Shah

Gender: male

Year Born:

Head of Legal & Secretarial and Compliance Officer
Mr. Kamlesh Kulkarni

Gender: male

Year Born:

Executive Chairperson
Ms. Ameera Sushil Shah

Gender: female

Year Born: 1979

Chief Scientific & Innovation Officer
Dr. Kirti Chadha

Gender: Not Specified

Year Born:

Head of Public Relations & Corporate Communications
Mr. Jeyasingh Balakrishnan

Gender: male

Year Born:

Chief Financial Officer
Mr. Sameer Prakash Patel

Gender: male

Year Born:

Chief Marketing Officer
Mr. Mohan Menon

Gender: male

Year Born:

Chief Executive Officer
Mr. Surendran Chemmenkotil

Gender: male

Year Born:

Chief People Officer
Ms. Diya Suri

Gender: female

Year Born:

FAQs about Metropolis Healthcare Limited

Who is the CEO of the company?

The CEO is Mr. Surendran Chemmenkotil.

What is the current market price of the stock?

The current price is ₹1,652.20.

What is the 52-week price range?

The range is ₹1315-2318.3.

What is the market capitalization of the company?

The market capitalization is ₹8,558.40 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 55.61.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Metropolis Healthcare Limited (ISIN: INE112L01020) is a leading Medical - Diagnostics & Research in India. With a market capitalization of ₹8,558.40 crores and an average daily volume of 85,070 shares, it operates in the Medical - Diagnostics & Research. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack